LD-2 disclosure · 4th Quarter - Report
FULCRUM THERAPEUTICS
Income$40Kfee reported
Client
- Description
- Rare disease biopharma company
- Location
- Massachusetts · United States of America
Registrant
- Description
- Consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Education and advocacy regarding sickle cell disease, including H.R. 1796/S. 735- Sickle Cell Disease and Other Heritable Blood Disorders, Research, Surveillance, Prevention, and Treatment Act of 2025. Priority review vouchers: Give Kids a Chance Act of 2025 (H.R. 1262/S.932)
LobbyistsJOHN MCMANUS
TargetedSENATE · HOUSE OF REPRESENTATIVES